Paul S. Plascjak

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™

Kayhan Garmestani, Diane E. Milenic, Paul S. Plascjak et al. · Nuclear Medicine and Biology · 2002 · 126 citations

Pharmacy, Biochemistry, Pharmaceutics +10

Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the α-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/<i>neu</i> Diabodies

Matthew K. Robinson, Calvin Shaller, Kayhan Garmestani et al. · Clinical Cancer Research · 2008 · 59 citations · Full text

Medicine, Immunology, Oncology +17

The Anti-CD25 Monoclonal Antibody 7G7/B6, Armed with the α-Emitter 211At, Provides Effective Radioimmunotherapy for a Murine Model of Leukemia

Meili Zhang, Zhengsheng Yao, Zhuo Zhang et al. · Cancer Research · 2006 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Preparation of 211At-Labeled Humanized Anti-Tac Using 211At Produced in Disposable Internal and External Bismuth Targets

Urs Schwarz, Paul S. Plascjak, Markus Beitzel et al. · Nuclear Medicine and Biology · 1998 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +11

Semi-remote production of [⁶⁴Cu]CuCl₂ and preparation of high specific activity [⁶⁴Cu]Cu-ATSM for PET studies

Lawrence P. Szajek, W. Meyer, Paul S. Plascjak et al. · Radiochimica Acta · 2005 · 45 citations

Natural Sciences, Chemistry, Nuclear Medicine +12